NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Virus Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Virus Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Epstein-Barr Virus



New Epstein-Barr virus data have been reported by B. Neuhierl and co-authors



June 16th, 2009

"Epstein-Barr virus (EBV) infection is mediated by several viral envelope glycoproteins. We have assessed gp110's functions during the virus life cycle using a mutant that lacks BALF4 (Delta BALF4)," scientists writing in the Journal of Virology report.

"Exposure of various cell lines and primary cell samples of epithelial or lymphoid lineages to the Delta BALF4 mutant failed to establish stable infections. The Delta BALF4 virus, however, did not differ from wild-type EBV in its ability to bind and become internalized into primary B cells, in which it elicited a potent T-cell-specific immune reaction against virion constituents. These findings show that Delta...


Source: Virus Weekly (2009-06-16)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login